6-Month DAPT Non-Inferior to Longer Tx Strategy

ACC Conference Reporter

ESC Congress 2016 | ROME — A 6-month regimen of dual antiplatelet therapy (DAPT) with clopidogrel was non-inferior to the practice of 18-month inhibition after stenting with a newer-generation drug-eluting device, the NIPPON study suggested. Read More >>>

Keywords: ESC Congress

< Back to Listings